Revenue
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Research & development | — | — | — | — | — | — | — | — | — | — | — | — | — | $0 | $0 | $0 | — | — | — |
| Operating expenses | $423,032 | $445,827 | $910,648 | $720,428 | $1.6M | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating income | −$423,032 | −$445,827 | −$910,648 | −$720,428 | −$1.6M | $1.7M | −$1.9M | −$2.9M | −$2.9M | −$2.0M | −$2.7M | −$1.7M | −$1.3M | −$2.7M | −$4.8M | −$3.5M | — | — | — |
| EBITDA | −$423,032 | −$445,827 | −$910,648 | −$717,496 | −$1.6M | $1.7M | −$1.9M | −$2.9M | −$2.9M | −$2.0M | −$2.7M | −$1.7M | −$1.3M | −$2.5M | −$4.5M | −$3.0M | — | — | — |
| Net income | −$2.2M | −$377,310 | $47,204 | $850,596 | −$1.6M | −$1.4M | −$1.9M | −$3.0M | −$2.8M | −$2.1M | −$2.8M | −$1.8M | −$25.7M | −$5.0M | −$7.2M | −$4.6M | −$19.0M | −$17.0M | −$5.6M |
| Basic EPSper basic share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | $0.01 | -$0.01 | -$0.02 | -$0.05 | -$0.04 | — | — | — |
| Diluted EPSper diluted share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | $0.01 | -$0.02 | -$0.01 | -$0.05 | -$0.04 | — | — | — |
Reported shareholders